Results 271 to 280 of about 146,560 (338)

Intestinal Ultrasound Transmural Healing Was Associated With Improved Long‐Term Outcomes Among Patients With Endoscopic Remission: Results of a Prospective Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This a prospective study showing the benefit of intestinal ultrasound transmural healing on long term outcome among patient with partial and complete endoscopic healing in Crohn's disease. ABSTRACT Background STRIDE II guidelines recognise endoscopic healing as a main therapeutic target in Crohn's disease (CD).
Clara Yzet, Amélie Plancke, Franck Brazier, Lucien Grados, Elise Derval, Louise Ghilardi, Momar Diouf, Adrien Ollier, Mathurin Fumery   +8 more
wiley   +1 more source

Non-fistulous Bladder Ulceration in Crohn's Disease: A Rare Extraintestinal Manifestation. [PDF]

Cureus
Jazzar A, Beydoun S, Hallal M, Alameh W.
europepmc   +1 more source

Listeriosis Complicating Infliximab Treatment in Crohn's Disease

, 2016
Chen Fw
openalex   +1 more source

The Belgian Registry of Pediatric Crohn's disease (BELCRO) : growth status after 3 year follow up [PDF]

, 2014
Alliet, P, Bontems, P, De Greef, E, Hoffman, I, Mahanchie, J, Paquot, I, Smets, F, Van Biervliet, Stephanie, Van Steen, Kristel, Veereman-Wauters, G   +9 more
core  

Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum villin‐1 is a non‐invasive indicator of gut barrier damage and short‐term mortality in acutely decompensated cirrhosis. Incorporating villin‐1 assessment into risk stratification methods improves prognostic accuracy by capturing an essential, yet previously overlooked component of disease progression.
David Tornai, Boglarka Balogh, Aniko Csillag, Andras Budai, Andras Kiss, Peter Antal‐Szalmas, Gabor Mehes, Lukacs Barath, Tamas Tornai, Istvan Tornai, Zsuzsanna Vitalis, Nora Sipeki, Tamas Dinya, Attila Enyedi, Florian A. Rosenberger, Wim Laleman, Minneke J. Coenraad, Ferran Aguilar, Joan Claria, Richard Moreau, Jonel Trebicka, Maria Papp, on behalf of MICROB‐PREDICT and PREDICT study group of the EASL‐CLIF consortium   +22 more
wiley   +1 more source

P802 Impact of early use of immunomodulator on the outcomes of Crohn's disease: A Systematic Review and Meta-Analysis [PDF]

Jongman Yoo, Jin Young Yoon, Yu Kyung Jun, Hye Sun Lee, J J Park   +4 more
openalex   +1 more source

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
Eating disorders are common among individuals with IBD, with prevalence estimates ranging from 3% to 14% depending on the assessment method. Findings highlight the need for validated screening tools tailored to IBD. ABSTRACT Background and Aims Disentangling whether disordered eating is a cause, consequence or manifestation of inflammatory bowel ...
Quinn Goddard, Ante Markovinović, Paul E. Ronksley, Cynthia H. Seow, Christopher Ma, Abdel‐Aziz Shaheen, Gilaad G. Kaplan   +6 more
wiley   +1 more source

Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study. [PDF]

United European Gastroenterol J
Ukashi O, Lahat A, Ungar B, Levy H, Asher AT, Eidler P, Ben-Horin S, Eliakim R, Kopylov U.   +8 more
europepmc   +1 more source